Treatment of Helicobacter pylori Eradication Failures. (Q53938347)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Treatment of Helicobacter pylori Eradication Failures.	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12628073

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/12628073

title

Treatment of Helicobacter pylori Eradication Failures. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12628073

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/12628073

main subject

Helicobacter pylori

0 references

author

Javier P Gisbert

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12628073

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/12628073

author name string

José María Pajares

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12628073

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/12628073

publication date

1 April 2003

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12628073

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/12628073

published in

Current treatment options in gastroenterology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12628073

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/12628073

volume

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12628073

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/12628073

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12628073

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/12628073

page(s)

147-156

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12628073

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/12628073

cites work

[High eradication rates in Helicobacter pylori infection in patients with duodenal ulcer who failed previous eradication therapy]

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11938-003-0015-8

retrieved

21 January 2018

A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A triple therapy regimen after failed Helicobacter pylori treatments

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helicobacter pylori therapy: first-line options and rescue regimen

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salvage therapies after failure of Helicobacter pylori eradication with ranitidine bismuth citrate-based therapies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rifampin and rifabutin resistance mechanism in Helicobacter pylori

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: a meta-analysis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of antibiotic-resistant Helicobacter pylori.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized study comparing omeprazole with ranitidine as anti-secretory agents combined in quadruple second-line Helicobacter pylori eradication regimens

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Efficacy of a multistep strategy for Helicobacter pylori eradication: quadruple therapy with omeprazole, metronidazole, tetracycline and bismuth after failure of a combination of omeprazole, clarithromycin and amoxycillin]

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helicobacter pylori eradication in a clinical setting: success rates and the effect on the quality of life in peptic ulcer.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cure of Helicobacter pylori infection after failed primary treatment: one-center results from 120 patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadruple therapy?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Strategy for retreatment of therapeutic failure of eradication of Helicobacter pylori infection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of Helicobacter pylori eradication therapies: a single centre observational study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Third line treatment for Helicobacter pylori: a prospective, culture-guided study in peptic ulcer patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regular review: treatment of Helicobacter pylori infection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro anti-Helicobacter pylori activities of new rifamycin derivatives, KRM-1648 and KRM-1657.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Highly Effective Second-Line Anti-Helicobacter pyloriTherapy in Patients with Previously Failed Metronidazole-Based Therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rifabutin-based 'rescue therapy' for Helicobacter pylori infected patients after failure of standard regimens

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rifabutin-based triple therapy after failure of Helicobacter pylori eradication treatment: preliminary experience.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rifabutin-based Helicobacter pylori eradication 'rescue therapy'.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ranitidine bismuth citrate therapy regimens for treatment of Helicobacter pylori infection: a review.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of a multistep strategy for Helicobacter pylori eradication.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quadruple therapy is effective for eradicating Helicobacter pylori after failure of triple proton-pump inhibitor-based therapy: a detailed, prospective analysis of 21 consecutive cases

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Re-treatment after Helicobacter pylori eradication failure.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12628073

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S11938-003-0015-8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12628073

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/12628073

PubMed publication ID

12628073

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12628073

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/12628073

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53938347&oldid=2212327069"